By Adrian Galbreth
A new treatment for a major eye disorder has been praised by one patient who has benefitted significantly from it.
Mike Scholes, 58, from Lindfield in West Sussex, recently took part in a trial for the drug idebenone, which is used to treat Leber's Hereditary Optic Neuropathy (LHON) – a condition he was diagnosed with five years ago.
According to Mr Scholes, his vision deteriorated to the point where he was struggling to make out objects close to his face, and as a result took part in the trial for idebenone.
After just six weeks he noticed the area affected in the centre of his vision was smaller and he also began to make out colours again, with his vision improving further in the following weeks.
He added: "I can use a computerised viewer to help me read, I can get dressed without having to use a detector for the colours of clothes and while initially I couldn't even see the eye chart, now if I get really close to a street sign I can read it."
by Martin Burns